May 25, 2023 — New data presented from an investigator-sponsored European trial found managing indicated1 heart failure patients with Abbott's CardioMEMS HF System resulted in a significant1 improvement in patient-reported quality-of-life scores as early as three months after u
May 26, 2023 — Atrial fibrillation, or AFib , is the most common heart rhythm problem, affecting millions of Americans and greatly increasing their risk of stroke and heart failure. For some with AFib, a catheter ablation is used to burn or freeze the precise area causing the problem to restore a normal heart rhythm.
May 25, 2023 — Boston Scientific Corporation announced data supporting use of the company's key electrophysiology and cardiac rhythm management therapies, and the WATCHMAN FLXLeft Atrial Appendage Closure (LAAC) Device.
May 25, 2023 — Abbott announced late-breaking results from the AVEIR dual-chamber (DR) i2i Investigational Device Exemption (IDE) study, a large-scale study to assess the world's first dual-chamber leadless pacemaker, showing that the leadless pacemaker met its three
May 24, 2023 — Park Ridge, N.J.-based publisher Wainscot Media has named Laura Dowden as managing director, group publisher, of the medical group, taking over the role for Diane Vojcanin, who announced her retirement in March after leading the brands since acquired by Wainscot Media in 2019.
If you enjoy this content, please share it with a colleague
May 24, 2023 — The largest interventional study focused on pulmonary embolisms highlighted importance of rapid removal of blood clots for immediate and longer-term patient benefit during a recent conference which gathered interventional cardiologists from around the world.
May 24, 2023 — Rhythm Technologies, Inc., a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced the presentation of four studies at the Heart Rhythm Society’s annual meeting,